Quality of evidence: II-B, Strength of recommendation: 1 Panel level of agreement: In total agreement 87%, in partial agreement 13% Patients with ALF, HE, and at risk for an increase in ICP should be managed in a calm environment, with serum sodium monitoring (maintaining levels between 140 and 145 mmol/l) and HE treatment with lactulose and rifaximin
Barcode Number: RS/RN136 Ingredients: Vitamin C (as Ascorbic Acid), Glutathione, Glycerin, Medium Chain Triglycerides, Phospholipids (Soy), Natural Orange Flavour Contains ingredients partially derived from soy and coconuts Allergy advice: For allergens, see ingredients in bold
In a neonatal rat in vitro cardiomyocyte hypoxia/reoxygenation study, pre-treatment with trimetazidine reduced apoptosis and inflammation [157]
General Information about amlodipine and valsartan tablets Medicines are sometimes prescribed for conditions that are not mentioned in the patient information leaflet